Position
Creative Planning in Mineralys Therapeutics, Inc.
Back to the book · All holders of MLYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$194.1K$36.29 → $27.09
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 21.1K | $765.8K | — | — | — | 0.0% |
| Q1 2026 | 24.3K | $658.3K | $27.09 | −$194.1K | $86.6K | 0.0% |